SCHEMBL6159855

SCHEMBL6159855

CC(C)(C)OC(=O)Nc1cccc(O[Si](C)(C)C(C)(C)C)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP17A1 P05093 1/20 0.46
NAMPT P43490 1/20 0.46
TDP2 O95551 1/20 0.45
HDAC6 Q9UBN7 4/20 0.45
HDAC3 O15379 3/20 0.45
HDAC1 Q13547 3/20 0.45
HDAC2 Q92769 3/20 0.45
HDAC8 Q9BY41 3/20 0.45
PDK1 Q15118 1/20 0.44
PDK2 Q15119 1/20 0.44
PDK3 Q15120 1/20 0.44
PDK4 Q16654 1/20 0.44
CA12 O43570 1/20 0.43
CA1 P00915 1/20 0.43
CA9 Q16790 1/20 0.43
KAT6A Q92794 1/20 0.43
HDAC10 Q969S8 2/20 0.43
MAPK1 P28482 2/20 0.43
RXFP1 Q9HBX9 1/20 0.43
FAAH O00519 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7683016 0.85 PDK1 (0.47) PDK1PDK2PDK3PDK4MAPK1
SCHEMBL24968488 0.83 PSMB8 (0.50) CYP17A1NAMPTTDP2HDAC6HDAC3
SCHEMBL281590 0.81 RAB9A (0.59) PDK1PDK2PDK3PDK4MAPK1
SCHEMBL29029431 0.81 HDAC3 (0.56) CYP17A1NAMPTHDAC6HDAC3HDAC1
SCHEMBL4791491 0.80 CA12 (0.46) CYP17A1NAMPTHDAC6HDAC3HDAC1
SCHEMBL26785208 0.80 MAPK1 (0.50) CYP17A1NAMPTTDP2HDAC6HDAC3
SCHEMBL5894005 0.79 CA2 (0.52) CYP17A1NAMPTHDAC6HDAC3HDAC1
SCHEMBL3892771 0.79 ALDH1A1 (0.52) CYP17A1TDP2HDAC6HDAC3HDAC1
SCHEMBL296753 0.79 HDAC3 (0.47) CYP17A1NAMPTTDP2HDAC6HDAC3
SCHEMBL999347 0.79 KMT2A (0.61) CYP17A1TDP2HDAC6HDAC3HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1226119-B1 TYROSINE KINASE INHIBITORS MERCK & CO INC (US) 2005-03-16 EP disclosed
EP-1226119-A4 TYROSINE KINASE INHIBITORS MERCK & CO INC (US) 2003-04-09 EP disclosed
US-6479512-B1 TO TREAT TYROSINE KINASE-DEPENDENT DISEASES AND CONDITIONS, SUCH AS ANGIOGENESIS, CANCER, TUMOR GROWTH, ATHEROSCLEROSIS, AGE RELATED MACULAR DEGENERATION, DIABETIC RETINOPATHY, INFLAMMATORY DISEASES, ETC. MERCK & CO., INC. 2002-11-12 US disclosed
EP-1226119-A2 TYROSINE KINASE INHIBITORS MERCK & CO. INC. (US) 2002-07-31 EP disclosed
WO-2001028993-A2 TYROSINE KINASE INHIBITORS MERCK & CO. INC. (US) 2001-04-26 WO disclosed